Ihle JN - Search Results

1

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients.

Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN. Brenner MK, et al. Among authors: ihle jn. Lancet. 1993 Nov 6;342(8880):1134-7. doi: 10.1016/0140-6736(93)92122-a. Lancet. 1993. PMID: 7901474

2

An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.

Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J Jr, Krance RA, Ihle JN, Brenner MK. Rill DR, et al. Among authors: ihle jn. Blood. 1992 May 15;79(10):2694-700. Blood. 1992. PMID: 1316784 Free article.

3

Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.

Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK. Rill DR, et al. Among authors: ihle jn. Hum Gene Ther. 1992 Apr;3(2):129-36. doi: 10.1089/hum.1992.3.2-129. Hum Gene Ther. 1992. PMID: 1391032

4

Gene marking and autologous bone marrow transplantation.

Brenner MK, Rill DR, Moen RC, Krance RA, Heslop HE, Mirro J Jr, Anderson WF, Ihle JN. Brenner MK, et al. Among authors: ihle jn. Ann N Y Acad Sci. 1994 May 31;716:204-14; discussion 214-5, 225-7. doi: 10.1111/j.1749-6632.1994.tb21713.x. Ann N Y Acad Sci. 1994. PMID: 8024195 Review.

5

Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells.

Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN, Brenner MK. Rill DR, et al. Among authors: ihle jn. Blood. 1994 Jul 15;84(2):380-3. Blood. 1994. PMID: 8025266 Free article.

6

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN. Brenner MK, et al. Among authors: ihle jn. Lancet. 1993 Jan 9;341(8837):85-6. doi: 10.1016/0140-6736(93)92560-g. Lancet. 1993. PMID: 8093407

7

Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.

Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE. Stute N, et al. Among authors: ihle jn. Blood. 1992 Jun 1;79(11):2849-54. Blood. 1992. PMID: 1375115 Free article.

8

Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.

Brown MP, Nosaka T, Tripp RA, Brooks J, van Deursen JM, Brenner MK, Doherty PC, Ihle JN. Brown MP, et al. Among authors: ihle jn. Blood. 1999 Sep 15;94(6):1906-14. Blood. 1999. PMID: 10477719 Free article.

9

Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer.

Bunting KD, Sangster MY, Ihle JN, Sorrentino BP. Bunting KD, et al. Among authors: ihle jn. Nat Med. 1998 Jan;4(1):58-64. doi: 10.1038/nm0198-058. Nat Med. 1998. PMID: 9427607

10

Effects of recombinant human hematopoietic growth factors on leukemic blasts from children with acute myeloblastic or lymphoblastic leukemia.

Mirro J Jr, Hurwitz CA, Behm FG, Head DR, Raimondi SC, Crist WM, Ihle JN. Mirro J Jr, et al. Among authors: ihle jn. Leukemia. 1993 Jul;7(7):1026-33. Leukemia. 1993. PMID: 8321018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters